SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-04-205837
Filing Date
2004-12-01
Accepted
2004-12-01 14:17:45
Documents
4
Period of Report
2004-11-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K FOR CORTEX PHARMACEUTICALS, INC. d8ka.htm 8-K/A 22851
2 LETTER FROM ERNST & YOUNG LLP, DATED NOVEMBER 30, 2004 dex162.htm EX-16.2 4845
4 GRAPHIC g22122image.jpg GRAPHIC 2570
5 LETTER TO THE SEC STAFF dcorresp.htm CORRESP 7720
  Complete submission text file 0001193125-04-205837.txt   40674
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-16467 | Film No.: 041176916
SIC: 2834 Pharmaceutical Preparations